Michael Tardugno

Michael Tardugno

Chairman at IMUNON, INC.

Net worth: 131 045 $ as of 2026-06-29

75 year
Health Technology
Process Industries
Consumer Services

Profile

Mr. Michael H.
Tardugno
is an Executive Chairman at Imunon, Inc. Mr. Tardugno was previously employed as a Senior Vice President & General Manager by Mylan Technologies, Inc., an Executive Vice President by Songbird Holdings LLC, a Senior Vice President-Technical Operations by Bristol Myers Squibb Co., a Senior Vice President-Technical Operations by Convatec, Inc., a Plant Manager-Ross Laboratories Division by Abbott Laboratories, and a VP-Technology Development & Manufacturing by Bausch & Lomb, Inc. He also served on the board at THO Inc.,.
He received his undergraduate degree from St. Bonaventure University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-07-16 73,621 ( 2.92% ) 131 045 $ 2026-06-29

Michael Tardugno active positions

CompaniesPositionStart
IMUNON, INC. Chairman 2014-10-06

Former positions of Michael Tardugno

CompaniesPositionEnd
Chief Operating Officer 2006-11-30
Corporate Officer/Principal 2004-12-31
Chief Tech/Sci/R&D Officer 1997-12-31
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 1997-12-31
Corporate Officer/Principal 1994-12-31
See the detail of Michael Tardugno's experience

Training of Michael Tardugno

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Tardugno